AnxietyNCT03711344
Culturally Adapting CBT for Chinese Youth in Ontario
A study testing Cognitive Behavioral Therapy in people with Anxiety and Depression, run by Centre for Addiction and Mental Health at 1 site in Canada.
Trial summary
This mixed methods study proposes a culturally adapted cognitive behavioural therapy (CA-CBT) model for a Chinese demographic in Canada. The client population of Chinese youth who have been diagnosed with anxiety and/or depression are the focus of the study. Read more about this study
- Who is it for?
- Ages 12 to 21 years
- Conditions the study is for
- Anxiety, Depression
- What is being tested?
- Cognitive Behavioral Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteCanada
- Study dates
- 4 Jan 2019to 30 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 21 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Self identification as Chinese origin
- Between the ages of 12 to 21
- Diagnosed as having depression and/or anxiety
Who cannot join
- Have been affected by psychosis
- Have been affected by serious addiction
- Have been affected by cognitive impairment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Improving Access to High Quality, Culturally Relevant Treatment for Chinese Youth in Ontario
This mixed methods study proposes a culturally adapted cognitive behavioural therapy (CA-CBT) model for a Chinese demographic in Canada. The client population of Chinese youth who have been diagnosed with anxiety and/or depression are the focus of the study. CBT has been proven as a very effective form of therapy, and when adapted can promote positive mental health outcomes for a growing and increasingly vulnerable population. Developing a culturally adapted version of CBT (CA-CBT) for this population adds a practical treatment that improves access to culturally relevant care.
Read the detailed description
There is a major lack of culturally relevant mental health services for Chinese youth in Ontario and Canada. Beginning with a participatory/qualitative research approach, common themes amongst clients, caregivers, healthcare professionals, and community leaders, will divulge basic elements needed to develop a culturally adapted model of Cognitive Behavioural Therapy. The information from the adapted model will be taught to participating psychologists who will deliver the therapy in a pre- and post- evaluation design, with feasibility testing of the intervention using a quantitative approach ensuing. Immediate guidelines will then be developed for use by therapists working with Chinese youth.
- Conditions
- Anxiety, Depression
- Being tested
- Cognitive Behavioral Therapy
- Keywords
- Cognitive Behavioral Therapy, Cultural Adaptation, Chinese Youth
- Medical subject headings
- Anxiety Disorders, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cognitive Behavioral TherapyBehavioural
The intervention will be administered by therapists working at community agencies who are experienced at providing Cognitive Behavioral Therapy.
| Study group | Role | What they receive |
|---|---|---|
| Culturally adapted Cognitive Behavioral Therapy | Experimental | The experimental group will receive the culturally adapted version of cognitive behavioral therapy. Receives: Behavioral: Cognitive Behavioral Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Severity levels of depression and anxiety rated by the Hospital Anxiety and Depression Scale (HADS).
Severity levels of depression and anxiety will be rated pre- and post-intervention by the Hospital Anxiety and Depression Scale (HADS). The scale ranges from 0 to 21 for anxiety and 0 to 21 for depression. A score of 0 to 7 for depression and/or anxiety is considered a normal range. A score of 8 to 10 suggests the potential presence of depression and/or anxiety. A score of 11 or more suggests a likely presence of depression and/or anxiety.
Measured: 4 months.
Severity levels of depression and anxiety rated by the Bradford Somatic Inventory (BSI).
Severity levels of depression and anxiety will be rated pre- and post-intervention by the Bradford Somatic Inventory (BSI). The Bradford Somatic Inventory uses "yes" or "no" questions relating to somatic symptoms of anxiety and/or depression. A "yes" response to a question equates to a somatic symptom linked to depression and/or anxiety. The maximum number of "yes" responses is 46 and the minimum is 0. A higher number of "yes" responses suggests a potential increase in the severity of depression and/or anxiety.
Measured: 4 months.
Secondary outcomes (1)
Satisfaction of the culturally adapted Cognitive Behavioral Therapy assessed using the Verona Satisfaction Scale.
Satisfaction will be measured using the Verona Satisfaction Scale. This scale measures patients satisfaction with health care services. The items are rated by 4 categories labelled: "strongly disagree", "disagree", "agree", and "strongly agree", on a scale of 1 to 4. A higher sub-scale/domain score indicates better satisfaction. All sub-scales are summed up to compute total/domain score. This scale will be used to identify the strengths and weaknesses of the therapy service and provide guidance for further development.
Measured: 4 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Oct 2018
- Study start4 Jan 2019
- Primary completion30 Dec 2019
- Study completion30 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnxietyStudies of the same condition, open and under way.
- More trials run by Centre for Addiction and Mental HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Chinese youth diagnosed with anxiety and/or depression will receive the culturally adapted Cognitive Behavioural Therapy. The severity of the anxiety and/or depression will be evaluated pre- and post-intervention.
- Masking
- None (open label)
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- University, hospital or other
- Collaborators
- East Metro Youth Services, Hong Fook Mental Health Association, Ontario Centre of Excellence for Child and Youth Mental Health
- Responsible party
- Sponsor
- Investigators
- Farooq Naeem, M.D., Principal investigator, Centre for Addiction and Mental HealthMyra Levy, M.A., Study director, East Metro Youth Services
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03711344
- Sponsor's protocol ID
- innovation-1927
- Status last verified
- Jan 2019
- First submitted
- 11 Sep 2018
- Last updated
- 28 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Access to High Quality, Culturally Relevant Treatment for Chinese Youth in Ontario
- ClinicalTrials.gov ID
- NCT03711344
- Acronym / sponsor ID
- innovation-1927
- Conditions
- Anxiety, Depression
- Keywords
- Cognitive Behavioral Therapy, Cultural Adaptation, Chinese Youth
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Centre for Addiction and Mental HealthUniversity, hospital or other
- Collaborators
- East Metro Youth Services, Hong Fook Mental Health Association, Ontario Centre of Excellence for Child and Youth Mental Health
- Study start
- 4 Jan 2019 (actual)
- Primary completion
- 30 Dec 2019 (actual)
- Study completion
- 30 Dec 2019 (actual)
- First posted
- 18 Oct 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This mixed methods study proposes a culturally adapted cognitive behavioural therapy (CA-CBT) model for a Chinese demographic in Canada. The client population of Chinese youth who have been diagnosed with anxiety and/or depression are the focus of the study. CBT has been proven as a very effective form of therapy, and when adapted can promote positive mental health outcomes for a growing and increasingly vulnerable population. Developing a culturally adapted version of CBT (CA-CBT) for this population adds a practical treatment that improves access to culturally relevant care.
Detailed description
There is a major lack of culturally relevant mental health services for Chinese youth in Ontario and Canada. Beginning with a participatory/qualitative research approach, common themes amongst clients, caregivers, healthcare professionals, and community leaders, will divulge basic elements needed to develop a culturally adapted model of Cognitive Behavioural Therapy. The information from the adapted model will be taught to participating psychologists who will deliver the therapy in a pre- and post- evaluation design, with feasibility testing of the intervention using a quantitative approach ensuing. Immediate guidelines will then be developed for use by therapists working with Chinese youth.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Chinese youth diagnosed with anxiety and/or depression will receive the culturally adapted Cognitive Behavioural Therapy. The severity of the anxiety and/or depression will be evaluated pre- and post-intervention.
| Arm | Type | Receives |
|---|---|---|
| Culturally adapted Cognitive Behavioral Therapy | Experimental | Behavioral: Cognitive Behavioral TherapyThe experimental group will receive the culturally adapted version of cognitive behavioral therapy. |
Who may qualify
- Ages
- 12 to 21 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Self identification as Chinese origin
- Between the ages of 12 to 21
- Diagnosed as having depression and/or anxiety
Key exclusion criteria (3 listed)
- Have been affected by psychosis
- Have been affected by serious addiction
- Have been affected by cognitive impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cognitive Behavioral TherapyThe intervention will be administered by therapists working at community agencies who are experienced at providing Cognitive Behavioral Therapy. | Behavioural | Culturally adapted Cognitive Behavioral Therapy |
Primary outcome
Severity levels of depression and anxiety rated by the Hospital Anxiety and Depression Scale (HADS).
Time frame: 4 months.
Severity levels of depression and anxiety will be rated pre- and post-intervention by the Hospital Anxiety and Depression Scale (HADS). The scale ranges from 0 to 21 for anxiety and 0 to 21 for depression. A score of 0 to 7 for depression and/or anxiety is considered a normal range. A score of 8 to 10 suggests the potential presence of depression and/or anxiety. A score of 11 or more suggests a likely presence of depression and/or anxiety.
Severity levels of depression and anxiety rated by the Bradford Somatic Inventory (BSI).
Time frame: 4 months.
Severity levels of depression and anxiety will be rated pre- and post-intervention by the Bradford Somatic Inventory (BSI). The Bradford Somatic Inventory uses "yes" or "no" questions relating to somatic symptoms of anxiety and/or depression. A "yes" response to a question equates to a somatic symptom linked to depression and/or anxiety. The maximum number of "yes" responses is 46 and the minimum is 0. A higher number of "yes" responses suggests a potential increase in the severity of depression and/or anxiety.
1 secondary outcome
Satisfaction of the culturally adapted Cognitive Behavioral Therapy assessed using the Verona Satisfaction Scale.
Time frame: 4 months.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Apr 2026.
Related trials for Anxiety
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Farooq Naeem, M.D. principal investigator
Centre for Addiction and Mental Health
Myra Levy, M.A. study director
East Metro Youth Services
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cognitive Behavioral Therapy in people with Anxiety and Depression, run by Centre for Addiction and Mental Health at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Severity levels of depression and anxiety rated by the Hospital Anxiety and Depression Scale (HADS). (time frame: 4 months.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.